India vs United States of America: Proportion of the target population who received 3 doses of
India
94.0%
in 2024
United States of America
94.0%
in 2024
India rank
72nd
United States of America rank
72nd
Proportion of the target population who received 3 doses of over time
- India
- United States of America
How they compare
India currently reports 94.0% against 94.0% in United States of America, a difference of 0.0%.
Across all 25 years both countries report, United States of America has been ahead every year.
India ranks 72nd and United States of America ranks 72nd of 209 countries.
United States of America has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | India | United States of America | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 63.8% | 95.3% | 31.5% | United States of America |
| 2010s | 85.6% | 94.6% | 9.0% | United States of America |
| 2020s | 89.6% | 93.8% | 4.2% | United States of America |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received 3 doses of, India or United States of America?
- India, at 94.0% against 94.0% in United States of America as of 2024.
- What is the difference in proportion of the target population who received 3 doses of between India and United States of America?
- 0.0%, with India ahead.
- How many years of comparable data are there for India and United States of America?
- 25 years are reported by both, from 2000 to 2024.
- How do India and United States of America rank globally for proportion of the target population who received 3 doses of?
- India ranks 72nd and United States of America ranks 72nd of 209 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received 3 doses of diphtheria-tetanus-pertussis (DTP3) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.